Osage University Partners is among the returning backers that have helped push Stanford-linked Dice Molecules’ total funding to around $200m.
Dice Molecules, a US-based biopharmaceutical spinout of Stanford University, closed a $60m series C1 round yesterday backed by spinout-focused venture capital fund Osage University Partners.
RA Capital Management and Sands Capital co-led the round, which was filled out by Janus Henderson Investors, Deep Track Capital, Logos Capital, Northpond Ventures, Eventide Asset Management, Driehaus Capital Management, Soleus Capital, New Leaf Venture Partners and Asymmetry Capital.
Founded in 2014, Dice Molecules is working on a drug discovery platform for oral…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
